,69 Furthermore, agonistic anti-CD40 antibodies increase the effectiveness of DC vaccines by reducing T cell tolerance and enhancing antigen-specific cytotoxic T cell responses in tumor-bearing mice.70 Here, CD40 is linked to neoplasm.